Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chloride channels and Chloride Intracellular Ion Channel (CLIC) proteins are a diverse group of proteins essential for maintaining cellular homeostasis through the transport of chloride ions across biological membranes (UniProt, 2024). Chloride channels, such as the CLC family and the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), regulate cell volume, transepithelial salt transport, and membrane excitability (IUPHAR/BPS Guide to Pharmacology, 2023). The CLIC family is unique due to its metamorphic nature, where proteins transition from a soluble state to a membrane-bound ion channel form, playing roles in organelle acidification and signal transduction (PubMed, PMID: 31554185). Mutations in these proteins lead to various channelopathies, including cystic fibrosis, myotonia congenita, and Dent's disease (NIH, 2023). In oncology, CLIC1 and CLIC4 are frequently overexpressed and contribute to tumor progression and metastasis, making them emerging therapeutic targets (PubMed, PMID: 28634143). Current drugs targeting these proteins include CFTR modulators like Ivacaftor and correctors like Lumacaftor, as well as ClC-2 activators like Lubiprostone for gastrointestinal disorders (StatPearls, 2024).
Pharmacological modulation includes CFTR potentiation (increasing channel open probability), CFTR correction (improving protein folding and trafficking), activation of ClC-2 channels to increase intestinal fluid secretion, and allosteric modulation of GABA-A receptors to enhance inhibitory neurotransmission.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chloride channel and Chloride Intracellular Ion Channel (CLIC) protein (ClC and CLIC).